The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Common antibiotic may be cost-saving treatment for reducing maternal sepsis: Study
Administering oral doses of the antibiotic azithromycin to pregnant individuals could potentially serve as a cost-effective measure for mitigating maternal sepsis, mortality, or infection in developing nations. This conclusion stems from a study incorporating data from seven countries, including India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 13, 2024 Category: Pharmaceuticals Source Type: news

Biocon Biologics focusing on market share gains of biosimilars in key markets
Biocon Biologics is focused on improving cash flows and increasing market shares of its biosimilar products, particularly in the US and Europe. The company is dealing with rising pricing pressure and delays in key approvals. The integration of Viatris' biosimilar business, acquired for $3.34 billion, has been completed in 120 countries, one year ahead of schedule. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 13, 2024 Category: Pharmaceuticals Source Type: news

Publish monthly list of spurious drugs, DCGI tells state bodies
The document states the draft regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of central and state drug authorities. "This guideline will be useful for effective surveillance for quality and efficacy of drugs and cosmetics by adopting uniform drug sampling methodology for drug inspectors under drug regulatory authorities of state and central," it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 13, 2024 Category: Pharmaceuticals Source Type: news

Chemists' body asks Mankind to drop health supplement ad featuring Ranveer Singh
"The content implies that vegetarian individuals are at risk of vitamin deficiency, suggesting that your product can prevent this," the AIOCD has said in its letter to Rajiv Juneja, managing director of Mankind Pharma, the makers of HealthOk. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2024 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma may take a $20-million hit this quarter
The company said it is planning to resume manufacturing operations in a phased manner starting with non-aseptic lines. The US regulatory agency issued Form 483 with 9 observations against the facility at the conclusion of the inspection on February 2. The company, as an "abundant caution", put on hold manufacturing at certain lines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2024 Category: Pharmaceuticals Source Type: news

GlaxoSmithKline Pharma q3 net declines 72%
Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2024 Category: Pharmaceuticals Source Type: news

Pulsar Capital-owned TruDoc buys Mumbai's Wellthy Therapeutics
Wellthy Therapeutics is backed by Ranjan Pai, GrowX and BeeNext. TruDoc Healthcare, the leading telehealth and virtual care provider in the GCC, has acquired Wellthy Therapeutics, a Mumbai-based platform specializing in chronic disease management. Wellthy, a digital therapeutics company, focuses on developing and deploying digital therapeutic solutions across various medical fields, including cardiology, nephrology, and diabetes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2024 Category: Pharmaceuticals Source Type: news

USFDA grants VAI classification to Dr Reddy's R&D centre
Dr Reddy's Laboratories announced that its Hyderabad-based R&D centre has received Voluntary Action Indicated (VAI) classification from the US FDA after an inspection. This classification indicates that objectionable conditions or practices were found, but no further administrative or regulatory action is required. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2024 Category: Pharmaceuticals Source Type: news

ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
ChrysCapital is close to acquiring 5-6% stake in La Renon Healthcare, a pharmaceutical company engaged in manufacturing and marketing of branded generic formulations. ChrysCapital will buy shares from early angel investors and possibly from promoter Pankaj Singh and family. La Renon's nutritional supplement brand is featured in the top 300 formulation brands in the domestic market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 11, 2024 Category: Pharmaceuticals Source Type: news

Anti-obesity drug market gaining traction in India
According to research firm Pharmarack, the market has tripled in two years after witnessing a sluggish growth till 2021. Over the last five years, the market has grown at 32% CAGR to 474 crore in January 2024. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 8, 2024 Category: Pharmaceuticals Source Type: news

Biocon CFO Indranil Sen resigns
Sen was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down. He has over 20 years of experience in financial planning, treasury, taxation and financial reporting. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 8, 2024 Category: Pharmaceuticals Source Type: news

MSD breaks ties with agency involved with Poonam Pandey
MSD, the Indian affiliate of US drug giant Merck, has terminated its association with Schbang, the creative marketing solutions agency involved in the controversial publicity stunt by model Poonam Pandey faking her own death. Schbang, along with Pandey and media outlet Hauterfly, carried out the stunt to raise awareness about cervical cancer, but it backfired. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 6, 2024 Category: Pharmaceuticals Source Type: news

US leans on India's pharma industry to snub China. There's just one catch
America's reliance on China for drug ingredients has raised alarm bells in Congress. House committees will hold two hearings Tuesday on drug shortages and the US Food and Drug Administration's foreign inspection program, which has seen a large drop in visits to Chinese factories over the last few years, due in large part to the Covid pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 5, 2024 Category: Pharmaceuticals Source Type: news

Thyrocare to buy home ECG service provider Think Health
Diagnostic provider Thyrocare, backed by Pharmeasy, will acquire a 100% stake in Chennai's Think Health Diagnostics to venture into providing at-home electrocardiogram (ECG) services. The deal, completed on February 1, allows Thyrocare to strengthen its position as a leading diagnostics at-home healthcare service provider and expand into the insurance segment, offering a comprehensive solution for blood and ECG testing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 5, 2024 Category: Pharmaceuticals Source Type: news

Unlocking Pharma Manufacturing Agility: Innovations for Reliability, Flexibility, and Growth
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 5, 2024 Category: Pharmaceuticals Source Type: news